The usefulness of (18)F-FDG PET/CT for assessing methotrexate-associated lymphoproliferative disorder (MTX-LPD)

BACKGROUND: Methotrexate-associated lymphoproliferative disorder (MTX-LPD) is a benign lymphoid proliferation or malignant lymphoma in patients who have been treated with MTX. MTX withdrawal and observation for a short period should be considered in the initial management of patients who develop LPD...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Shiro, Manabe, Osamu, Hirata, Kenji, Oyama-Manabe, Noriko, Hattori, Naoya, Kikuchi, Yasuka, Kobayashi, Kentaro, Toyonaga, Takuya, Tamaki, Nagara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986273/
https://www.ncbi.nlm.nih.gov/pubmed/27528380
http://dx.doi.org/10.1186/s12885-016-2672-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986273/
https://www.ncbi.nlm.nih.gov/pubmed/27528380
http://dx.doi.org/10.1186/s12885-016-2672-8

Ejemplares similares